U.S. Semiconductors Stock News

Google’s TurboQuant algorithm announcement, which aims to cut AI memory needs, shook semiconductor sentiment. Photronics (PLAB) dropped 6.8% as investors quickly reassessed demand expectations for memory related manufacturing businesses. See our latest analysis for Photronics. That sharp 6.8% drop comes after a stronger run, with the share price showing a 20.11% 90 day return and an 18.53% year to date return, while the 1 year total shareholder return of 92.23% highlights how much sentiment...

Worthington Enterprises (WOR) has put fresh numbers on the table, with third quarter fiscal 2026 results showing higher sales, earnings and earnings per share, supported by acquisitions and data center related demand. See our latest analysis for Worthington Enterprises. The latest earnings update, buyback progress and ongoing dividends come against a mixed share price backdrop, with a 7 day share price return of 6.42% contrasting with a 30 day share price decline of 9.48%, while the 3 year...

Genesis Energy (GEL) is facing a sexual assault lawsuit in Harris County State Court that names the company and a current board member, with Jane Doe seeking US$50 million in compensatory and punitive damages. See our latest analysis for Genesis Energy. The lawsuit lands at a time when Genesis Energy’s share price, now at US$17.78, has pulled back 2.79% over one day but still carries an 11.96% year to date share price return and an 18.10% one year total shareholder return. This builds on a...

Recent Performance Snapshot Merchants Bancorp (MBIN) has drawn fresh attention after a mixed short term return pattern, with a 2.2% decline over the past day, a 2.6% gain over the past week, and a flat month. See our latest analysis for Merchants Bancorp. Looking beyond the latest moves, the 90 day share price return of 26.44% sits alongside a 1 year total shareholder return of 15.44%. This suggests recent momentum has been stronger than the longer term outcome. If you are comparing Merchants...

If you are wondering whether BlackRock's current share price reflects its true value, you are not alone. This article focuses exactly on that question. The stock last closed at US$933.85, with returns of 0.7% over 1 year, 49.8% over 3 years, and 37.2% over 5 years, while the year to date return sits at a 13.9% decline and the past month shows a 12.2% decline. Recent coverage has centered on BlackRock's role as a major global asset manager, its influence across exchange traded funds, and its...

If you are wondering whether Flowserve's current share price still offers value, it helps to look past the headline moves and focus on what the underlying numbers are saying about the stock. The share price recently closed at US$72.15, with returns of 1.1% over 7 days, a 18.5% decline over 30 days, 2.0% year to date, 50.0% over 1 year, 123.1% over 3 years, and 102.4% over 5 years. This gives a mixed picture of shorter term swings versus longer term performance. Recent coverage around...

Genpact stock moves: recent performance snapshot Genpact (G) has drawn investor attention after a period of weaker share performance, with the stock showing a 2.2% decline over the past day and deeper losses over the past month and past 3 months. See our latest analysis for Genpact. At a share price of US$36.58, Genpact’s recent 7 day and 30 day share price returns of 5.48% and 7.91% declines, alongside a 1 year total shareholder return of 25.62% decline, suggest momentum has been fading as...

Federal Realty Investment Trust (NYSE:FRT) has acquired the Congressional North Shopping Center in Montgomery County, Maryland. The property is located along Rockville Pike in the Washington DC Metro area, a densely populated and affluent retail corridor. The deal expands Federal Realty's ownership cluster in one of the country's most established retail corridors. Federal Realty Investment Trust, a retail focused REIT, is known for owning and operating open air shopping centers and mixed...

If you are asking whether Amprius Technologies at US$16.12 is still attractively priced or already running ahead of itself, the next sections walk through the key numbers you need to weigh that up. The stock has been volatile recently, with an 11.4% decline over the past 7 days, a 50.2% gain over 30 days, an 84.4% return year to date and a very large 1 year return of 473.7%. Recent coverage has focused on Amprius as a high growth, high volatility name in the Electrical industry, and those...

In March 2026, Ligand Pharmaceuticals expanded its leadership team by appointing healthcare investors Peter Renehan, MD, and Lee Brown as Vice Presidents of Investments and Business Development, while broadening Lauren Hay’s role to Vice President of Portfolio Strategy and Investments to focus on royalty financing and portfolio optimization. Around the same time, Chief Financial Officer Octavio Espinoza sold 3,057 shares for about US$688,000 under a prearranged 10b5-1 plan, alongside company...

In March 2026, Ingles Markets and activist investor Summer Road LLC entered a heated proxy fight, filing competing proxy statements over board seats and a non-binding executive pay proposal ahead of the April 30, 2026 annual meeting. This contest highlights growing shareholder pressure on Ingles Markets’ governance and executive compensation practices, putting board composition and accountability under closer scrutiny. Next, we will examine how this proxy contest over board representation...

Recent share performance and business context MongoDB (MDB) has drawn investor attention after a period of weaker share performance, with the stock showing negative returns over the past week, month and past 3 months, alongside a negative year to date move. This share price backdrop sits against annual revenue of US$2.46b and a reported net loss of US$71.15m, raising questions about how investors should weigh growth in its database platform against profitability and valuation today. See our...

Regeneron Pharmaceuticals (REGN) is back in focus after Japan’s Ministry of Health, Labour and Welfare approved Dupixent for adults with moderate to severe bullous pemphigoid, expanding the drug’s footprint in a rare inflammatory skin disease. See our latest analysis for Regeneron Pharmaceuticals. Even with the positive Dupixent news, Regeneron’s short term share price return has been muted. The 7 day share price return is 0.66% and the 30 day share price return reflects a 5.62% decline. The...

Dollar General announced in March 2026 that Jerry “JJ” Fleeman Jr., a veteran Ahold Delhaize USA executive, will succeed Todd Vasos as CEO and join the Board on January 1, 2027, with Vasos remaining as a Senior Advisor through April 2, 2027 and continuing as a director thereafter. This leadership transition brings deep grocery and digital expertise into a business already reshaped under Vasos by DG Fresh, pOpshelf, international expansion, and enhanced delivery and loyalty programs. Next,...

Wondering if Huntington Ingalls Industries at around US$381.79 is still offering value after a strong run, or if the easy gains are already behind it. The stock has seen a 6.4% decline over the past 7 days and a 14.1% decline over the past 30 days, while the 1 year return stands at 89.4% and the 3 year and 5 year returns are 96.7% and 108.6% respectively. Recent attention on the company has centered on its role in U.S. defense and shipbuilding programs. This often keeps investors focused on...

Commerce Bancshares stock snapshot after recent performance Commerce Bancshares (CBSH) shares recently closed at US$48.07, with the stock showing a 1 day return of 1.88% and a past month decline of 5.73%, extending to 8.75% over the past 3 months. See our latest analysis for Commerce Bancshares. Stepping back, the recent softness in the 1 month share price return of 5.73% and 3 month share price return of 8.75% sits alongside a 1 year total shareholder return of 16.49%. This may indicate...

Recent performance snapshot Hims & Hers Health (HIMS) has drawn investor attention after a mixed run, with the share price near US$19.38 and returns ranging from a 33% gain over the past month to a 43% decline over the past 3 months. See our latest analysis for Hims & Hers Health. The recent pullback, including a 7.1% 1 day share price decline and weaker year to date share price return, sits against a much stronger 3 year total shareholder return of 95.4%. This suggests that momentum has...

Norwegian Cruise Line Holdings (NYSE:NCLH) has entered a cooperation agreement with Elliott Investment Management. The company is appointing five new directors to the board, including leaders from travel, finance, and investment sectors. CEO John Chidsey is also becoming Board Chairman as part of the governance changes. Norwegian Cruise Line Holdings runs a global cruise operation, competing with other large operators for leisure travel demand. The cruise sector has been influenced by...

Why Bitdeer’s latest moves matter for BTDR stock Bitdeer Technologies Group (BTDR) has put fresh attention on its stock with two developments: a new SEALMINER DL1 Air Scrypt mining machine and unaudited February 2026 operating metrics showing expanded hash rate and mining activity. See our latest analysis for Bitdeer Technologies Group. The latest product launch and operating update come after a mixed year for investors. The share price is US$8.37, with a 1 month share price return of 8.7%,...

Why CSX’s upcoming earnings and locomotive upgrade matter now CSX (CSX) heads into its April 22 first quarter earnings report with attention on a recent US$670 million agreement with Wabtec to modernize its Evolution Series locomotive fleet for fuel efficiency and reliability gains. See our latest analysis for CSX. CSX’s 1-year total shareholder return of 38.35% and 3-year total shareholder return of 38.37% sit against a 9.37% year to date share price return and an 8.03% 90 day share price...

PHINIA stock at a glance PHINIA (PHIN) is catching investor attention after recent share price swings, with a last close at $67.11 and returns ranging from a 7% gain over the past week to a 7.6% decline over the month. See our latest analysis for PHINIA. Recent moves have been choppy, with a 7% 7 day share price return following a 7.6% 30 day share price decline. At the same time, the 1 year total shareholder return of 58.9% points to momentum that has been strong over a longer stretch. If...

Privosegtor data presentation puts Oculis Holding (OCS) in focus Oculis Holding (NasdaqGM:OCS) is coming into focus after announcing that ACUITY Phase 2 data for its investigational therapy Privosegtor in acute optic neuritis will be presented at the NANOS 2026 meeting. See our latest analysis for Oculis Holding. At a share price of $24.69, Oculis has seen a 16.05% 1 month share price decline after strong longer term momentum, including a 23.45% 3 month share price return and a 232.30% 3 year...

What Semtech’s Recent Share Performance Tells You Semtech (SMTC) has drawn investor attention after a recent pullback, with the share price down 2.7% over the past day and about 20% over the past month, despite strong longer term returns. See our latest analysis for Semtech. The recent 30 day share price return of a 20% decline, alongside a 4.1% year to date share price decline, contrasts with a 1 year total shareholder return of 105.9%. This suggests that momentum has cooled after a strong...

Diodes (DIOD) is back on investor radar after expanding its PowerDI8080-5 automotive-compliant N-channel MOSFET line with a new ultra-low RDS(ON) 100V device aimed at demanding electric vehicle systems. See our latest analysis for Diodes. The product launch arrives after a strong 90 day share price return of 36.35% and a 1 year total shareholder return of 57.43%. However, the 3 and 5 year total shareholder returns remain negative, suggesting recent momentum is building off a weaker long term...